Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 14 04:00PM ET
58.22
Dollar change
-0.28
Percentage change
-0.49
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.S. Return% 1Y- Shs Outstand Perf Week-0.59%
SponsorJPMorgan Chase ETF Type Tagsequity Return% 3Y- Total Holdings68 Perf Month-0.15%
Fund Family Bond Type Tagshealthcare Return% 5Y- AUM7.28M Perf Quarter1.10%
Index- Average Maturity Tagsbiotechnology Return% 10Y NAV% Perf Half Y12.16%
Index Weighting Commodity Type Tagspharmaceutical Return% SI NAV/sh Perf Year-
Active/Passive Quant Type Tags- Flows% 1M0.00% 52W Range48.43 - 58.80 Perf YTD8.06%
Dividend TTM0.08 (0.14%) ESG Type Tags- Flows% 3M-15.97% 52W High-0.99% Beta-
Dividend Ex-DateDec 19, 2023 Dividend Type Sector/Theme Flows% YTD-36.93% 52W Low20.21% ATR (14)0.34
Expense0.65% Structure Type Region Flows% 1Y RSI (14)56.49 Volatility0.38% 0.15%
Option/ShortNo / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume4.72 Prev Close58.51
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume0.45K Price58.22
SMA200.64% SMA502.04% SMA2005.36% Trades Volume2,147 Change-0.49%
Jpmorgan Healthcare Leaders ETF seeks to provide long-term capital appreciation. The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.